Crimean congo hemorrhagic fever: Requires vigilance and not panic

Journal of Association of Physicians of India

Volumn 59, Issue 3, 2011, Pages 164-167

  Bajpai, Smrati ^a   Nadkar, Milind Y ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RIBAVIRIN;

ANIMAL; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE TRANSMISSION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INDIA; ISOLATION AND PURIFICATION; NAIRO VIRUS; PANIC; PARASITE VECTOR; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; RISK FACTOR; TICK; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; ARACHNID VECTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INDIA; PANIC; POLYMERASE CHAIN REACTION; PROGNOSIS; RIBAVIRIN; RISK FACTORS; TICKS;

EID: 79952497988     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. th 2011 report.
2. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Research 2004; 64:145-160.
3. Chumakov MP. A new tick-borne virus disease-Crimean hemorrhagic fever. In: Sokolov; Acute Infectious capillary Toxicosis; Izd. Otd. Primorskoi Armii, Simferopol, moscow;1945, 13-45.
4. Butenko AM, Chumakov MP, Bashkirtsev VN, et al. Isolation and investigation of Astrakhan strain ("Drozdov") of Crimean hemorrhagic fever virus and data on serodiagnosis of this infection. mater. 15 Nauchn. Sess. Inst. Polio Virus Entsefalitov (moscow) 3, 88-90.
5. Marriot AC, Nutall PA. Molecular biology of nairoviruses; Elliot, r.m. (Ed.), The Bunyaviridae. Plenum Press, New York 1996:91-104.
6. Dickson DL, Turell MJ. Replication and tissue tropisms of Crimean- congo hemorrhagic fever virus in experimentally infected adult Hyalomma truncatum. Med Entomol 1992;29:767-773.
7. Mardani M, Jahromi MK, et al. The efcacy of oral ribavirin in the treatment of Crimean-congo hemorrhagic fever in Iran. Clin Infect Dis 2003;36:1613-1618.
8. Karti S, Odabasi S, Korten Z, et al. Crimean-congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004;10:1379-1384.
9. Weekly epidemiological record, No. 44, 29 October 2010.
10. Mardani M, Keshtkar-Jahromi M. Crimean-congo hemorrhagic Fever. Arch Iranian Med 2007;10:204-214.
11. Swanepoel R., Shepherd A.J. et al. Epidemiologic and clinical features of Crimean-congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg 1987;36:120-132.
12. chinikar S, Mirahmadi R, Mazaheri V, Nabeth P, Saron MF. A survey of Crimean-congo hemorrhagic fever in Iran. Clin Microbiol Infect 2003;9(suppl 1):81.
13. Hoogstraal H. The epidemiology of tick-borne Crimean-congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979;15:307-417.
14. Vasilenko SM, Vassilev TL et al. Specific intravenous immunoglobulin for Crimean-congo haemorrhagic fever. Lancet 1990;335:791-792.
15. connor JD. Ribavirin pharmacokinetics. Pediatr Infect Dis J 1990;9(suppl): S91-S92.
16. Soares-Weiser K, Thomas S, Thomson GG and Garner P. Ribavirin for Crimean-congo hemorrhagic fever: systematic review and meta-analysis. BMC Infectious Diseases 2010;10:207.
17. Frame JD. Clinical features of Lassa fever in Liberia. Rev Infect Dis 1989;11(suppl 4):783-789.
18. Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, et al. Human mxA protein inhibits the replication of Crimean-congo hemorrhagic fever virus. J Virol 2004;78:4323-4329.
19. Van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Michell WL, et al. A Nosocomial outbreak of Crimean-congo hemorrhagic fever at Tygerberg hospital. Part I. clinical features. S Afr Med J 1985;68:711-715.
20. Centers for Disease control and Prevention. Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb Mortal Wkly Rep 1983;32(suppl 2):27-38.
21. Shuman M. Abnormalities of platelet and vascular function. In: Goldman L, Bennet JC, eds. Cecil Textbook of Medicine. 21st ed. Philadelphia: WB Saunders company 2000;996-1012.
22. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, et al. Crimean-congo hemorrhagic fever in eastern Turkey: clinical features, risk factors, and efficacy of ribavirin therapy. J Infect 2006;52:207-215.
23. Van Eeden PJ, Joubert JR, van de Wal, BW, King JB, de Kock A, Groenewald Jh. A nosocomial outbreak of Crimean-congo haemorrhagic fever at Tygerberg hospital. Part I. clinical features. S Afr Med J 1985;68:711-717.
24. Fisher-Hoch SP, Khan JA, rehman S, mirza S, Khurshid M, Mc-Cormick JB. Crimean-congo haemorrhagic fever treated with oral ribavirin. Lancet 1995;346:472-475.
25. Papa A, Bino S, Llagami A, et al. Crimean-congo hemorrhagic fever in Albania. Eur J Clin Microbiol Infect Dis 2001;21:603-606.
26. Mardani M. Crimean-congo hemorrhagic fever. In: mortazavi-Tabatabaei SA, ed. Important Zoonoses in Iran. Tehran: ministry of health and Education 2005;219-220.